Genedrive
Gino Miele is the Chief Scientific Officer at genedrive, where Gino develops IVD assays and workflows for rapid nucleic acid-based point-of-care diagnostics. With a background in molecular biology and gene expression, Gino has held various roles in research and development at companies like Cytomos and Epistem Ltd. Gino has also contributed to the field of functional genomics at institutions such as the University of Dundee and University Hospital Zurich. Throughout their career, Gino has focused on biomarker identification and validation across different therapeutic areas.
Genedrive
The Genedrive® molecular diagnostic system has been developed as an affordable next generation genotyping and sequence analysis device, providing rapid detection in approximately 45-75 minutes depending on the test.